Has Nelle Linz, MD received payments from drug or device companies?

Yes. Drug and device makers reported $576 in general payments to Nelle Linz, MD across 28 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nelle Linz, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nelle Linz, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nelle Linz, MD

Cardiovascular Disease · Suffolk, VANPI 1750352613

Payments from drug & device makers

$576in general payments, 2019–2025

Across 28 payments — averaging $20.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$287
Cardiovascular Systems Inc.$183
Boston Scientific$29
Biotronik Inc.$28
Chiesi USA, Inc.$22
Medtronic$16
plus $11 from 1 others

What the payments were for

Food & beverage$54895%
Education$285%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	15	$287
Cardiovascular Systems Inc.	8	$183
Boston Scientific	1	$29
Biotronik Inc.	1	$28
Chiesi USA, Inc.	1	$22
Medtronic	1	$16
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$11

How this compares

$576 in reported general payments places this provider in the 30th percentile of 548 cardiovascular disease providers in Virginia.

See all cardiovascular disease providers in Virginia →

Medicare billing

Part B allowed, 2024

$26,747

Medicare patients

306

Services billed

433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	15	$13,938
Rosuvastatin Calcium	39	$760
Nitroglycerin	11	$668
Losartan Potassium	27	$323
Ezetimibe	12	$245
Isosorbide Mononitrate ErIsosorbide Mononitrate	14	$183
Metoprolol Succinate	12	$179
Carvedilol	18	$161
Amlodipine Besylate	19	$105
Furosemide	12	$86
Metoprolol Tartrate	14	$59

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Suffolk

Tariq HaddadFalls Church$8M
David LimCharlottesville$6M
Hamid TaheriManassas$4.9M
Philip OdonnellWinchester$4.6M
Antonio AbbateCharlottesville$4M
George VetrovecRichmond$2.3M
Henry TranFalls Church$1.6M
John SchmedtjeRoanoke$1.4M
Jonathan LindnerCharlottesville$941K
Christopher KramerCharlottesville$929K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →